For the quarter ending 2025-11-30, CBIH had -$91 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-11-30 | 2025-08-31 | 2025-05-31 |
|---|---|---|---|
| Net loss | -116,967 | -82,645 | -548,820 |
| Issuance of common stock for services | 0 | 0 | 220,000 |
| Amortization of right-of-use asset and liability | 0 | 0 | 32,875 |
| Credit cards | - | 0 | 97 |
| Loss on valuation of convertible notes | - | - | 29,322 |
| Change in value of derivative liabilities | 0 | 29,322 | - |
| Accrued interest | - | 0 | 22,095 |
| Accounts receivable | 12,845 | 2,586 | -13,759 |
| Deferred revenue | - | 12,000 | 0 |
| Bank overdraft | - | 0 | -2,408 |
| Related party receivables | - | - | 9,155 |
| Accounts payable and accrued expenses | 115,164 | 952 | -65,515 |
| Related party payable | 21,155 | - | - |
| Lease liability (net) | 0 | -2,111 | -21,877 |
| Net cash used in operations | -5,493 | -103,712 | -329,627 |
| Proceeds from issuance of common stock | - | - | 244,250 |
| Proceeds from (repayments of) short-term loans | - | - | -24,472 |
| Proceeds from sales of common stock | - | 0 | - |
| Proceeds from shareholders loans | - | - | 7,538 |
| Change in lease liabilities | - | 0 | - |
| Proceeds from (repayments of) short-term loans | 0 | - | 9,182 |
| Change in notes payable | - | 2,818 | - |
| Proceeds from (payment of) notes payable | -9,082 | - | 139 |
| Repayment of sba loans | 0 | 0 | - |
| Repayment of related-party loan | - | 0 | 0 |
| Proceeds from shareholder loans | 0 | - | - |
| Proceeds from related-party loan | 11,666 | 93,801 | 105,187 |
| Net cash provided by financing activities | 5,402 | 90,983 | 341,824 |
| Net increase (decrease) in cash | -91 | -12,729 | 12,197 |
| Cash at beginning of period | 12,952 | 12,952 | 755 |
| Cash at end of period | 12,952 | 223 | 12,952 |
Cannabis Bioscience International Holdings, Inc. (CBIH)
Cannabis Bioscience International Holdings, Inc. (CBIH)